Related Subjects:
|Iron deficiency Anaemia
|Haemolytic anaemia
|Macrocytic anaemia
|Megaloblastic anaemia
|Microcytic anaemia
|Myelodysplasia
|Myelofibrosis
|Hereditary Spherocytosis
|Hereditary Elliptocytosis
๐งฌ Hereditary Hemorrhagic Telangiectasia (HHT), also known as OslerโWeberโRendu disease, is a rare autosomal dominant vascular disorder.
It causes fragile blood vessels (telangiectasias and AVMs) prone to bleeding, affecting the skin, mucous membranes, lungs, liver, and brain.
Early diagnosis and treatment are essential to prevent serious complications such as GI bleeding, haemorrhagic stroke, and paradoxical emboli.
๐ About
- Definition: Genetic disorder causing abnormal blood vessel formation (telangiectasia, AVMs).
- Inheritance: Autosomal dominant - only one abnormal gene needed to manifest ๐ช.
- Sites involved: Skin, mucous membranes, lungs, liver, brain ๐ง .
- Family history: Common; many affected individuals have a first-degree relative.
- Prevalence: ~1 in 5,000โ8,000 worldwide ๐.
๐ Brain AVMs occur in ~10% of HHT patients, while pulmonary AVMs (PAVMs) are present in the majority.
Screening for AVMs is critical to prevent life-threatening complications.
๐งฌ Aetiology
- Disorder of angiogenesis โ malformed, fragile vessels.
- Genes: ENG (HHT1), ACVRL1 (HHT2), SMAD4 (HHT/Juvenile Polyposis overlap).
- Genotypeโphenotype correlation:
- HHT1: ENG mutation, โ risk of brain AVMs (13%).
- HHT2: ACVRL1 mutation, lower brain AVM risk (2%).
- SMAD4: Associated with GI polyposis + HHT.
๐ง Stroke Mechanisms in HHT
- ๐ฅ Haemorrhage from ruptured cerebral AVMs.
- ๐ซ Paradoxical emboli via pulmonary AVMs โ ischaemic stroke.
- ๐ฉธ Fragility of GI vessels โ severe GI bleeds & anaemia.
โก Clinical Features
- ๐ Epistaxis: Recurrent nosebleeds (most common).
- ๐ฉธ GI bleeding: Haematemesis, melaena, iron deficiency anaemia (esp. >50 yrs).
- ๐ง Neurological: Haemorrhagic stroke (cerebral AVMs), embolic stroke (PAVMs).
- ๐ฉบ Mucocutaneous telangiectasia: Lips, oral cavity, nose, fingertips.
- ๐ซ Pulmonary AVMs: Can rupture โ haemoptysis, hypoxaemia.
๐ธ Clinical Signs
๐ Diagnostic Criteria (Curaรงao Criteria)
| Criterion | Description |
| Epistaxis | Spontaneous, recurrent nosebleeds ๐. |
| Mucocutaneous Telangiectasia | Lips, oral cavity, fingers, nose - blanchable pink-red spots ๐ด. |
| Visceral AVMs | Pulmonary, cerebral, hepatic, GI, spinal. |
| Family History | First-degree relative with confirmed HHT. |
โ
Definite HHT: โฅ3 criteria
โ ๏ธ Possible: 2 criteria
โ Unlikely: <2 criteria
๐ฌ Investigations
- Bloods: FBC, ferritin, iron studies, B12/folate.
- Brain: MRI/MRA for AVMs.
- Lungs: Bubble echocardiogram (screening), CT pulmonary angiogram if positive ๐ซ.
- GI tract: Endoscopy/colonoscopy ยฑ capsule endoscopy.
- Genetic testing: Confirms subtype, guides family screening ๐ช.
๐ฉบ Management
- Emergency: ABC resuscitation, transfusions, urgent intervention for GI bleed or haemorrhagic stroke ๐.
- Epistaxis: ENT laser ablation, cautery, nasal packing ๐.
- GI Bleeds: Iron replacement, endoscopic therapy ๐ฝ๏ธ.
- Pulmonary AVMs: Embolization via interventional radiology ๐ซ.
- Medical: Antifibrinolytics (tranexamic acid), avoid antithrombotics ๐ซ.
- Genetics: Genetic counselling for families ๐งฌ.
๐ Prognosis
- Chronic but variable disease course.
- Many lead normal lives with treatment โ
.
- Complications: GI bleeding, haemorrhagic stroke, embolic stroke.
- Early screening & treatment of AVMs improves long-term outcomes ๐ฑ.
๐ References